Created at Source Raw Value Validated value
March 31, 2021, 12:31 a.m. usa

- participant in another rct - myocarditis - patients who are already on beta-blockers patients already on nicorandil. . patients taking pde5 inhibitors or riociguat .shock as defined by sbp<90 for more than 30 minutes not responding to iv fluids with evidence of end organ damage. .severe bradycardia (<50 bpm). .heart block greater than first-degree (except in patients with a functioning artificial pacemaker). .decompensated heart failure. .sick sinus syndrome (unless a permanent pacemaker is in place). .severe hepatic impairment (child-pugh class c) or active liver disease. .unexplained persistent elevations of serum transaminases. .pregnancy or breastfeeding. .hypersensitivity to any of the medications. - can't take medications orally - patient refuses to participate

- participant in another rct - myocarditis - patients who are already on beta-blockers patients already on nicorandil. . patients taking pde5 inhibitors or riociguat .shock as defined by sbp<90 for more than 30 minutes not responding to iv fluids with evidence of end organ damage. .severe bradycardia (<50 bpm). .heart block greater than first-degree (except in patients with a functioning artificial pacemaker). .decompensated heart failure. .sick sinus syndrome (unless a permanent pacemaker is in place). .severe hepatic impairment (child-pugh class c) or active liver disease. .unexplained persistent elevations of serum transaminases. .pregnancy or breastfeeding. .hypersensitivity to any of the medications. - can't take medications orally - patient refuses to participate

Jan. 10, 2021, 12:31 a.m. usa

- participant in another rct - myocarditis - patients who are already on beta-blockers .patients already on statins. patients already on nicorandil. . patients taking pde5 inhibitors or riociguat .shock as defined by sbp<90 for more than 30 minutes not responding to iv fluids with evidence of end organ damage. .severe bradycardia (<50 bpm). .heart block greater than first-degree (except in patients with a functioning artificial pacemaker). .decompensated heart failure. .sick sinus syndrome (unless a permanent pacemaker is in place). .severe hepatic impairment (child-pugh class c) or active liver disease. .unexplained persistent elevations of serum transaminases. .pregnancy or breastfeeding. .hypersensitivity to any of the medications. - can't take medications orally - patient refuses to participate

- participant in another rct - myocarditis - patients who are already on beta-blockers .patients already on statins. patients already on nicorandil. . patients taking pde5 inhibitors or riociguat .shock as defined by sbp<90 for more than 30 minutes not responding to iv fluids with evidence of end organ damage. .severe bradycardia (<50 bpm). .heart block greater than first-degree (except in patients with a functioning artificial pacemaker). .decompensated heart failure. .sick sinus syndrome (unless a permanent pacemaker is in place). .severe hepatic impairment (child-pugh class c) or active liver disease. .unexplained persistent elevations of serum transaminases. .pregnancy or breastfeeding. .hypersensitivity to any of the medications. - can't take medications orally - patient refuses to participate

Nov. 19, 2020, 12:31 a.m. usa

. patients who are already on beta-blockers .patients already on statins. patients already on nicorandil. .shock as defined by sbp<90 for more than 30 minutes not responding to iv fluids with evidence of end organ damage. .severe bradycardia (<50 bpm). .heart block greater than first-degree (except in patients with a functioning artificial pacemaker). .decompensated heart failure. .sick sinus syndrome (unless a permanent pacemaker is in place). .severe hepatic impairment (child-pugh class c) or active liver disease. .unexplained persistent elevations of serum transaminases. .pregnancy or breastfeeding. .hypersensitivity to any of the medications.

. patients who are already on beta-blockers .patients already on statins. patients already on nicorandil. .shock as defined by sbp<90 for more than 30 minutes not responding to iv fluids with evidence of end organ damage. .severe bradycardia (<50 bpm). .heart block greater than first-degree (except in patients with a functioning artificial pacemaker). .decompensated heart failure. .sick sinus syndrome (unless a permanent pacemaker is in place). .severe hepatic impairment (child-pugh class c) or active liver disease. .unexplained persistent elevations of serum transaminases. .pregnancy or breastfeeding. .hypersensitivity to any of the medications.